Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 72 record(s)

Req # A-2021-00135

Requesting Briefing note S19098: “Statistics Canada’s Release of Police-Reported Hate Crime.”

Organization: Crown-Indigenous Relations and Northern Affairs Canada

40 page(s)
November 2021

Req # A-2021-00152

The number of private investigators/firms acquired to search for alleged perpetrators to do with the Indian residential schools system between 2005-2021, and the total cost.

Organization: Crown-Indigenous Relations and Northern Affairs Canada

2 page(s)
November 2021

Req # A-2016-001559

Briefing materials provided by Health Canada to Brigadier-General H.C. MacKay (Surgeon General of the Canadian Armed Forces), and his office, regarding the drug Mefloquine also known under the brand name Lariam from July 1, 2016 to September 30, 2016.

Organization: Health Canada

3 page(s)
November 2021

Req # A-2017-000580

Documents submitted by sponsor in support of the safe use of Mannitol in this formulation indicated for the management of nausea and vomiting of pregnancy as well as all other documents, materials, regarding: PMS-DOXYLAMINE-PYRIDOXINE (Drug Identification Number (DIN 02406187)).

Organization: Health Canada

868 page(s)
November 2021

Req # A-2021-000242

The number of analysts/public servants processing access to information files, broken down by year and by category at Health Canada for the following years: 2015, 2016, 2017, 2018, 2019, 2020 and 2021 to date, May 14, 2021.

Organization: Health Canada

2 page(s)
November 2021

Req # A-2021-000934

Canary RX Inc ("Canary"), was granted licenses to cultivate, process and sell cannabis pursuant to the Cannabis Act in 2019 - they were required to submit a video evidence submission package - when Health Canada received the video evidence submission package, and when the license was received by Canary. The average time it took in both 2018 and 2019 between Health Canada receiving the video evidence packages and ultimately granting or denying licenses.

Organization: Health Canada

1 page(s)
November 2021

Req # A-2021-000939

A certified copy of the search results from the notice of compliance database for the "Brand/product name", CIALIS. If a certified copy of the search results cannot be provided, a certified copy of the notice of compliance dated September 17, 2003, for the drug product CIALIS (Drug Identification Numbers: 02248088 and 02248089).

Organization: Health Canada

2 page(s)
November 2021

Req # A-2021-000940

A certified copy of the search results from the notice of compliance database for the "Brand/product name", LEVITRA. If a certified copy of the search results cannot be provided, a certified copy of the notice of compliance dated March 17, 2004, for the drug product LEVITRA (Drug Identification Numbers: 02250462, 02250470 and 02250489).

Organization: Health Canada

2 page(s)
November 2021

Req # A-2021-000941

A certified copy of the search results from the notice of compliance database for the "Brand/product name", REVATIO. If a certified copy of the search results cannot be provided, a certified copy of the notice of compliance dated May 26, 2006, for the drug product REVATIO (Drug Identification Number. 02279401).

Organization: Health Canada

2 page(s)
November 2021

Req # A-2021-000962

All active contracts under Tier 1 TBIPS and Tier 2 TIBIPS with an initial contract value greater than $150,000.00, contract number, solicitation number, contract award date, contract end date and vendor.

Organization: Health Canada

1 page(s)
November 2021
Date modified: